Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program - Fierce Pharma

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Qihan Biotech's QT-019B Receives FDA RMAT and BTD - Business Wire

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Pharma Mar Says Jazz Pharmaceuticals To Seek FDA Withdrawal Of Zepzelca Second-line Use - TradingView

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Production problems hamper Lantheus bid for FDA approval of radiopharma dx kit - Fierce Biotech

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify - Fierce Biotech

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication - Fierce Pharma

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA issues warning letter to Aurobindo’s subsidiary - The Pharma Letter

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax - Pharma Voice

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Ionis Pharma (IONS): FDA Catalysts, Accelerating Revenue And A Path To 2028 Cash-flow Breakeven - RTTNews

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

US FDA Closes Aurolife Pharma Raleigh Plant Inspection With VAI Classification - BW Healthcare World

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Aurobindo Pharma Says US FDA Classifies Unit's Raleigh Plant As Voluntary Action Indicated - TradingView

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

NervGen Pharma (NGEN) Advances RESTORE Study with FDA Backing, F - GuruFocus

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026 - marketscreener.com

news.google.com · 18 Aug 2026

Google News – FDA (biotech/pharma) External News

Capricor soars on plan to amend DMD filing after adcomm setback - Fierce Biotech

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials - Nature

news.google.com · 18 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program - Fierce Pharma

Qihan Biotech's QT-019B Receives FDA RMAT and BTD - Business Wire

Pharma Mar Says Jazz Pharmaceuticals To Seek FDA Withdrawal Of Zepzelca Second-line Use - TradingView

Production problems hamper Lantheus bid for FDA approval of radiopharma dx kit - Fierce Biotech

FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify - Fierce Biotech

Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication - Fierce Pharma

FDA issues warning letter to Aurobindo’s subsidiary - The Pharma Letter

FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax - Pharma Voice

Ionis Pharma (IONS): FDA Catalysts, Accelerating Revenue And A Path To 2028 Cash-flow Breakeven - RTTNews

US FDA Closes Aurolife Pharma Raleigh Plant Inspection With VAI Classification - BW Healthcare World

Aurobindo Pharma Says US FDA Classifies Unit's Raleigh Plant As Voluntary Action Indicated - TradingView

NervGen Pharma (NGEN) Advances RESTORE Study with FDA Backing, F - GuruFocus

Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026 - marketscreener.com

Capricor soars on plan to amend DMD filing after adcomm setback - Fierce Biotech

CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials - Nature